Clinical Trial Update: Clinical Trial of Trelagliptin Succinate Tablets in the Treatment of Type 2 Diabetes [Phase 3]

View source ↗

Summary

Phase 3 trial update for trelagliptin succinate tablets in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Trelagliptin succinate tablets (trelagliptin succinate)

Snippet

Sponsor: CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED